From the Sector

Reset
3 results
Dr Ioana Slabu and Benedict Bauer with the nanomodified stent. Photo Peter Winandy
30.03.2023

Nanomodified polymerstent: Novel technology for tumour therapy

  • Electromagnetically heatable nanomodified stent for the treatment of hollow organ tumours wins second place at the RWTH Innovation Award

Almost every fourth person who dies of cancer has a hollow organ tumour, for example in the bile duct or in the oesophagus. Such a tumour cannot usually be removed surgically. It is only possible to open the hollow organ for a short time using a stent, i.e. a tubeshaped prosthesis. However, the tumour grows back and penetrates the hollow organ through the stent. Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have now developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award. This involves a polymerstent that contains magnetic nanoparticles. When electromagnetic fields are applied, these nanoparticles lead to a controlled heating of the stent material and thus of the tumour. Because the tumour reacts much more sensitively to heat than healthy tissue, it is destroyed and the hollow organ remains open. Thus, the stent develops a self-cleaning effect.  

  • Electromagnetically heatable nanomodified stent for the treatment of hollow organ tumours wins second place at the RWTH Innovation Award

Almost every fourth person who dies of cancer has a hollow organ tumour, for example in the bile duct or in the oesophagus. Such a tumour cannot usually be removed surgically. It is only possible to open the hollow organ for a short time using a stent, i.e. a tubeshaped prosthesis. However, the tumour grows back and penetrates the hollow organ through the stent. Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have now developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award. This involves a polymerstent that contains magnetic nanoparticles. When electromagnetic fields are applied, these nanoparticles lead to a controlled heating of the stent material and thus of the tumour. Because the tumour reacts much more sensitively to heat than healthy tissue, it is destroyed and the hollow organ remains open. Thus, the stent develops a self-cleaning effect.  

Ioana Slabu of the AME explains: "Not only can we drastically reduce treatment costs, but above all we can provide relief for millions of patients worldwide.
 
A manufacturing process and proof of concept for magnetic hyperthermia are already in place. This novel technology has a very high development potential because it can also be used for tumours in other parts of the body such as the prostate, stomach, intestine or urinary bladder or for cardiovascular diseases.  

The AiF/IGF project started under the project title "ProNano" funded by BMWK. Now the approval for the follow-up project "ProNano2" has also been received. The approved project is called: "Validation of the innovation potential of heatable stents for heat-induced treatment of cavity tumours" and is funded by BMBF in course of the VIP+ program. With the Clinic for General, Visceral and Transplantation Surgery of the University Hospital Aachen and the Institute for Technology and Innovation Management at RWTH Aachen University, the consortium is enriched by clinical and economic expertise. Every year, RWTH Aachen University honours particularly innovative university projects with the Innovation Award. Professor Malte Brettel, Prorector for Business and Industry, presented the certificates to four outstanding projects as part of RWTHtransparent.

Source:

ITA – Institut für Textiltechnik of RWTH Aachen University

Photo: AkzoNobel
Ben Noteboom
20.12.2022

Ben Noteboom to be nominated as AkzoNobel Supervisory Board member

AkzoNobel has announced that Ben Noteboom will be nominated as a member of the Supervisory Board at the Annual General Meeting being held in April 2023. The Supervisory Board intends to subsequently elect him as Chair, succeeding Nils Andersen, who will retire as Chair and member of the Supervisory Board at the same time.

Noteboom is Chairman of Vopak’s Supervisory Board and a member of the Supervisory Board of Aegon. He also chairs the Board of Trustees of the Cancer Center Amsterdam. His former roles include CEO and Chairman of the Board of Management at Randstad, while he held different management positions at Dow Chemicals for nearly nine years.

Commenting on the announcement, Byron Grote, says: “The Supervisory Board is very pleased to announce the nomination of Ben Noteboom. His strong track record in executive and non-executive roles, and his broad experience in different industries – including the chemical industry – will be valuable additions to AkzoNobel.”

AkzoNobel has announced that Ben Noteboom will be nominated as a member of the Supervisory Board at the Annual General Meeting being held in April 2023. The Supervisory Board intends to subsequently elect him as Chair, succeeding Nils Andersen, who will retire as Chair and member of the Supervisory Board at the same time.

Noteboom is Chairman of Vopak’s Supervisory Board and a member of the Supervisory Board of Aegon. He also chairs the Board of Trustees of the Cancer Center Amsterdam. His former roles include CEO and Chairman of the Board of Management at Randstad, while he held different management positions at Dow Chemicals for nearly nine years.

Commenting on the announcement, Byron Grote, says: “The Supervisory Board is very pleased to announce the nomination of Ben Noteboom. His strong track record in executive and non-executive roles, and his broad experience in different industries – including the chemical industry – will be valuable additions to AkzoNobel.”

Adds Ben Noteboom: “I’m excited about the opportunity to join AkzoNobel’s Supervisory Board and look forward to contributing to the next phase of the company’s transformation as it makes further progress to becoming a frontrunner in the industry.”

Source:

AkzoNobel

adidas Breast Cancer Awareness Collection - Free Hiker
16.09.2022

adidas launches Breast Cancer Awareness Collection

A Selection of Footwear and Apparel Designed to Raise Awareness and Funding for Breast Cancer Now and National Breast Cancer Foundation, Inc.

A Selection of Footwear and Apparel Designed to Raise Awareness and Funding for Breast Cancer Now and National Breast Cancer Foundation, Inc.

  • In partnership with the charities Breast Cancer Now (UK/Europe) and National Breast Cancer Foundation (US), the Collection brings together a range of products for running, hiking and mountain biking
  • £15/€15/$15 from each full-price sale will be donated to BCN (for purchases in the UK and EU) or NBCF (for purchases in the North America)
  • The Collection feature illustrations by adidas pro mountain biker Veronique Sandler, empathetically designed to represent the comfort that those with breast cancer have experienced in the outdoors

Inspired by the experiences of people and communities around the world, including its own employees and athletes, adidas is launching the Breast Cancer Awareness Collection this October.
Available throughout Breast Cancer Awareness Month, the adidas Breast Cancer Awareness Collection sees adidas partnering with Breast Cancer Now in the UK and Europe, and National Breast Cancer Foundation, Inc. in the US, to help raise awareness of breast cancer and support the vital work both charities do.

The products in the Breast Cancer Awareness Collection have been chosen to help everyone, regardless of physical ability or condition, spend more time in the outdoors.
The collection’s focus on functional footwear and apparel that is designed for the outdoors is in keeping with adidas' objective to help broaden access to outdoor sports and help everyone enjoy the benefits of spending time in nature. With United by Summits, adidas TERREX is taking this brand-wise ethos further by encouraging all people, from every background, to realise their own individual goals in the outdoors and enjoy the benefits of adventure, both big and small.

The collection is available for purchase in limited quantities from September 30, 2022 until the end of October 2022 for adiClub members only, and £15/€15/$15 from each full-price sale of the adidas Breast Cancer Awareness Collection will be donated to Breast Cancer Now (for purchases in the UK and EU) or National Breast Cancer Foundation, Inc. (for purchases in North America). The money raised will contribute to the important work these charities are doing.

More information:
adidas Charity breast cancer
Source:

adidas